pharmaceuticals, specifically drug reformulation regulatory gaming. …

Price controls create opportunities for international arbitrage. Many have argued that such arbitrage, if tolerated … pharmaceuticals. We challenge this orthodox view and show, to the contrary, that the pace of innovation often is faster in a world … conclusion is to recognize that governments will make different choices of price controls when parallel imports are allowed by …

the hypothesis that innovation in pharmaceuticals is becoming more difficult and expensive over time, as costs of …

creating an internal market for pharmaceuticals can be analysed. In a model of third-degree price discrimination, arbitrage … Market in pharmaceuticals are ambiguous, since a movement from segmented and price-controlled markets towards integrated … between two markets and price controls through governments in one market are introduced. The effects of easier arbitrage …

We provide a method allowing to identify margins in an oligopoly price competition game when prices may not be freely … from the US, Germany and France to identify country-specific demand models and then recover price cost margins under the … regulated price setting constraints on the French market. To do so, we estimate a structural model on the market for anti …

In this paper we estimate a New-Keynesian DSGE model with heterogeneity in price and wage setting behavior. In a recent … study, Coibion and Gorodnichenko (2011) develop a DSGE model, in which firms follow four different types of price setting … heterogeneity in wage rigidity, such as the persistence in price and the wage inflation, which a standard New Keynesian model with …